Affimed NV


Takeways from ASCO 2015: Innate Pharma SA, Oncothyreon Inc (USA), and Affimed NV

By Zack Fink and Jake King Innate Pharma SA¬†(EPA:IPH) presented data from the phase I dose-escalation study of lirilumab in patients with hematologic …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts